PL364699A1 - Modulation of immune response by ribavirin - Google Patents

Modulation of immune response by ribavirin

Info

Publication number: PL364699A1
Authority: PL; Poland
Prior art keywords: ribavirin; modulation; immune response; immune; response
Prior art date: 1999-01-29

Application number

PL99364699A

Other languages

Polish (pl)

Inventor

Robert Tam

Original Assignee

Icn Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-29

Filing date

1999-12-20

Publication date

2004-12-13

1999-12-20 Application filed by Icn Pharmaceuticals, Inc. filed Critical Icn Pharmaceuticals, Inc.

2004-12-13 Publication of PL364699A1 publication Critical patent/PL364699A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Oncology (AREA)
Pulmonology (AREA)
Virology (AREA)
Orthopedic Medicine & Surgery (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Neurology (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

PL99364699A 1999-01-29 1999-12-20 Modulation of immune response by ribavirin PL364699A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US24136799A	1999-01-29	1999-01-29

Publications (1)

Publication Number	Publication Date
PL364699A1 true PL364699A1 (en)	2004-12-13

Family

ID=22910442

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL99364699A PL364699A1 (en)	1999-01-29	1999-12-20	Modulation of immune response by ribavirin

Country Status (20)

Country	Link
EP (1)	EP1146883A4 (en)
JP (1)	JP2002535371A (en)
KR (1)	KR20020023939A (en)
CN (1)	CN1334736A (en)
AU (1)	AU2483300A (en)
BR (1)	BR9917090A (en)
CA (1)	CA2357735A1 (en)
CZ (1)	CZ20012519A3 (en)
HK (1)	HK1040937A1 (en)
HR (1)	HRP20010496A2 (en)
HU (1)	HUP0200027A2 (en)
IL (1)	IL144130A0 (en)
MX (1)	MXPA01007211A (en)
NO (1)	NO20013529L (en)
PL (1)	PL364699A1 (en)
RU (1)	RU2211698C2 (en)
SI (1)	SI20802A (en)
SK (1)	SK10092001A3 (en)
WO (1)	WO2000044388A1 (en)
ZA (1)	ZA200105595B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001290178A1 (en)	2000-08-17	2002-02-25	Tripep Ab	A hepatitis c virus non-structural ns3/4a fusion gene
RU2286172C2 (en)	2000-08-17	2006-10-27	Трипеп Аб	Ribavirin-containing vaccines and methods for their application
US6680059B2 (en)	2000-08-29	2004-01-20	Tripep Ab	Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en)	2000-08-17	2006-04-04	Tripep Ab	Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US20050182252A1 (en)	2004-02-13	2005-08-18	Reddy K. R.	Novel 2'-C-methyl nucleoside derivatives
SE534514C2 (en) *	2006-03-14	2011-09-20	Wholesome Biopharm Pty Ltd	Composition for the treatment of allergic diseases
EP2185195A2 (en)	2007-08-16	2010-05-19	Tripep Ab	Immunogen platform

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4211771A (en) *	1971-06-01	1980-07-08	Robins Ronald K	Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
EP0038629A1 (en) *	1980-04-17	1981-10-28	Beecham Group Plc	Virazole derivatives, process for their preparation and use as antiviral agents
BE902199A (en) *	1984-10-29	1985-07-31	Vira Tek Inc	METHOD OF MEDICAL TREATMENT OF VIRAL DISEASES USING 1-BETA-D-RIBOFURANNOSYL-1, 2,4-TRIAZOLE-3-CARBOXAMIDE.
AU5668886A (en) *	1986-03-27	1987-10-20	Harry Edward Gruber	A method of increasing adenosine excretion
US5030623A (en) *	1986-03-27	1991-07-09	The Regents Of The University Of California	Methods for increasing extracellular adenosine and for stabilizing mast cells
US5405837A (en) *	1993-05-18	1995-04-11	Indiana University Foundation	Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
RU2088232C1 (en) *	1995-02-14	1997-08-27	Государственный научный центр вирусологии и биотехнологии "Вектор"	Inhibitor of marburg virus reproduction
IL125088A0 (en) *	1996-01-23	1999-01-26	Icn Pharmaceuticals	Modulation of TH1/TH2 cytokine expression
US5767097A (en) *	1996-01-23	1998-06-16	Icn Pharmaceuticals, Inc.	Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
JP2002503212A (en) *	1996-10-16	2002-01-29	アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド	Monocyclic nucleosides, analogs and uses thereof

1999
- 1999-12-20 AU AU24833/00A patent/AU2483300A/en not_active Abandoned
- 1999-12-20 JP JP2000595690A patent/JP2002535371A/en not_active Withdrawn
- 1999-12-20 MX MXPA01007211A patent/MXPA01007211A/en unknown
- 1999-12-20 HK HK02102923.6A patent/HK1040937A1/en unknown
- 1999-12-20 BR BR9917090-6A patent/BR9917090A/en not_active IP Right Cessation
- 1999-12-20 WO PCT/US1999/030490 patent/WO2000044388A1/en not_active Ceased
- 1999-12-20 IL IL14413099A patent/IL144130A0/en unknown
- 1999-12-20 RU RU2001119056/14A patent/RU2211698C2/en not_active IP Right Cessation
- 1999-12-20 KR KR1020017009609A patent/KR20020023939A/en not_active Withdrawn
- 1999-12-20 HR HR20010496A patent/HRP20010496A2/en not_active Application Discontinuation
- 1999-12-20 CA CA002357735A patent/CA2357735A1/en not_active Abandoned
- 1999-12-20 SK SK1009-2001A patent/SK10092001A3/en unknown
- 1999-12-20 HU HU0200027A patent/HUP0200027A2/en unknown
- 1999-12-20 PL PL99364699A patent/PL364699A1/en not_active Application Discontinuation
- 1999-12-20 CZ CZ20012519A patent/CZ20012519A3/en unknown
- 1999-12-20 SI SI9920099A patent/SI20802A/en not_active IP Right Cessation
- 1999-12-20 EP EP99968159A patent/EP1146883A4/en not_active Withdrawn
- 1999-12-20 CN CN99815897A patent/CN1334736A/en active Pending
2001
- 2001-07-06 ZA ZA200105595A patent/ZA200105595B/en unknown
- 2001-07-17 NO NO20013529A patent/NO20013529L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CZ20012519A3 (en)	2002-05-15
HUP0200027A2 (en)	2002-04-29
RU2211698C2 (en)	2003-09-10
ZA200105595B (en)	2002-10-07
SI20802A (en)	2002-08-31
IL144130A0 (en)	2002-05-23
NO20013529D0 (en)	2001-07-17
EP1146883A1 (en)	2001-10-24
EP1146883A4 (en)	2004-11-24
WO2000044388A1 (en)	2000-08-03
CN1334736A (en)	2002-02-06
MXPA01007211A (en)	2002-05-06
KR20020023939A (en)	2002-03-29
HRP20010496A2 (en)	2003-08-31
JP2002535371A (en)	2002-10-22
NO20013529L (en)	2001-09-12
AU2483300A (en)	2000-08-18
BR9917090A (en)	2001-10-16
CA2357735A1 (en)	2000-08-03
SK10092001A3 (en)	2002-02-05
HK1040937A1 (en)	2002-06-28

Publication	Publication Date	Title
GB2352493B (en)	2003-03-19	Single piece piston
AU2002225512A1 (en)	2002-06-24	Immune system stimulation
EP1208556A4 (en)	2005-04-13	Motion simulator
GB0022010D0 (en)	2000-10-25	Cooker
IL145891A0 (en)	2002-07-25	Methods and compositions for modulating an immune response
EG22530A (en)	2003-03-31	Preparation of substituted piperidin-4-ones
IL144130A0 (en)	2002-05-23	Modulation of immune response by ribavirin
EP1218407A4 (en)	2003-01-08	Uses of kappa-conotoxin pviia
GB9929891D0 (en)	2000-02-09	Exciplexes
EP1300681A4 (en)	2004-07-14	Means of assaying immune function
GB9807062D0 (en)	1998-06-03	Immune response
GB9822619D0 (en)	1998-12-09	Immune response stimulation
GB0014437D0 (en)	2000-08-09	Immune response stimulation
GB2346223B (en)	2003-06-04	Governor
AU6074000A (en)	2001-01-22	Human immune response molecules
CA85813S (en)	1999-02-12	Walker
CA85805S (en)	1999-02-12	Walker
HUP9902379A2 (en)	2001-03-28	Firering and dust-separator apparatous to utilize plant-wastes by air-protecting way
GB9914659D0 (en)	1999-08-25	Easy walker
GB9924775D0 (en)	1999-12-22	Immune response stimulation
GB0121570D0 (en)	2001-10-24	Immune modulator
GB9920013D0 (en)	1999-10-27	Connected components
GB9915260D0 (en)	1999-09-01	Modification to the works of an airgun
GB9905127D0 (en)	1999-04-28	Child tracker
GB9919460D0 (en)	1999-10-20	Stalker

Legal Events

Date	Code	Title	Description
2007-02-28	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)